Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Tissue Engineering & Bioprinting: Research to Commercialization

Joseph Purita's Biography



Joseph Purita, Medical Director of Stem Cell Centers of America, Institute Of Regenerative and Molecular Orthopedics

Dr. Purita is currently director of Institute of Regenerative and Molecular Orthopedics (www.stemcellorthopedic.com) in Boca Raton, Florida. The Institute specializes in the use of Stem Cells and Platelet Rich Plasma injections for use in sports medicine and other musculoskeletal conditions. Dr. Purita is a pioneer in the use of Stem Cells and Platelet Rich Plasma for a variety of orthopedic conditions which previously required surgery. The Institute has treated some of the most prominent professional athletes from all major sports in both the U.S.A. and abroad. He received a B.S. degree from Georgetown Univ in 1972. He received his M.D. degree from Georgetown Univ. in 1976. Orthopedic residency was completed at the Univ. of Miami. Dr. Purita is board certified in Orthopedics by ABOS. He is a Fellow American College of Surgeons, Fellow American Academy Orthopedic Surgeons, and a Fellow American Academy of Pain Management. He is also certified in Age Management Medicine. He has consistently been named a top doctor by prestigious Castle Connolly and U.S. News and World Report. He is licensed to practice medicine in multiple states and countries. He has lectured and taught extensively throughout the world on the use of Stem Cells and Platelet Rich Plasma for musculoskeletal conditions. He has been instrumental in helping other countries in the world establish guidelines for the use of Stem Cells in their countries. He has been invited to lecture on these techniques throughout the world as a visiting professor. His lectures have been in many different settings and have been for CME credit both in the USA and abroad. Dr. Purita and his work have been profiled on ESPN, CNN, NYT, WSJ, S.I. and numerous other periodicals. He has also published in the United States and Abroad. These publications include chapters in the American Academy of Anti-Aging Medicine Volumes XII, XIV, XV, and XVI. He has also published in the Korean Stem Cell Society Journal. He currently has a book underway on Regenerative Medicine as it pertains to Stem Cells. He is also a member of the Teaching Facility of the American Academy of Ant-Aging Medicine Stem Cell Fellowship. He also acts as a consultant for a number of companies in the Stem Cell Industry. Dr. Purita’s institute acts as a magnet for physicians and academic people from all over the world to learn about Stem Cell and Platelet Rich Plasma treatments.

Joseph Purita Image

The Use Of PRP and Stem Cell injections in an Office Setting

Tuesday, 10 February 2015 at 09:00

Add to Calendar ▼2015-02-10 17:00:002015-02-10 18:00:00Europe/LondonThe Use Of PRP and Stem Cell injections in an Office SettingTissue Engineering and Bioprinting: Research to Commercialization in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com

This presentation concerns PRP and Stem Cell (both bone marrow and adipose) injections for musculoskeletal conditions in an office setting.  Indications are given as to which type of cell and technique to use to accomplish repair.  Stem cells, both bone marrow derived (BMAC) and adipose, are used for the more difficult problems..  PRP injections are utilized for the less severe tendon problems.  Discussed are the indications of when to use Stem Cells verses PRP and when to use both.  The newest concepts in stem cell science are presented. These concepts include the clinical use of MUSE cells, exosomes, and Blastomere like stem cells.  Basic science of both PRP and stem cells are discussed.  This presentation defines what constitutes an effective PRP preparation.  Myths concerning stem cells are dispelled.  One myth is that mesenchymal stem cells are the most important stem cell.  This was the initial interpretation of Dr.  Arnold Caplan the father of mesenchymal stem cell science.  Dr. Caplan now feels that MSCs have an immunomodulation capacity which may have a more profound and immediate effect on joint chemistry and biology.  We learn that the hematopoietic stem cells are the drivers of tissue regeneration.  Also discussed are adjuncts used which enhance the results. Therapies include supplements, LED therapy, laser, electrical stimulation, and cytokine therapy.  The scientific rationale is presented for each of these entities as to how they have a direct on stem cells.


Add to Calendar ▼2015-02-09 00:00:002015-02-10 00:00:00Europe/LondonTissue Engineering and Bioprinting: Research to CommercializationTissue Engineering and Bioprinting: Research to Commercialization in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com